ZA883957B - Compositions of catecholic butanes for use in treating tumors - Google Patents

Compositions of catecholic butanes for use in treating tumors

Info

Publication number
ZA883957B
ZA883957B ZA883957A ZA883957A ZA883957B ZA 883957 B ZA883957 B ZA 883957B ZA 883957 A ZA883957 A ZA 883957A ZA 883957 A ZA883957 A ZA 883957A ZA 883957 B ZA883957 B ZA 883957B
Authority
ZA
South Africa
Prior art keywords
compositions
treating tumors
catecholic butanes
catecholic
butanes
Prior art date
Application number
ZA883957A
Other languages
English (en)
Inventor
Edward S Neiss
S Neiss Edward
Larry M Allen
M Allen Larry
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Publication of ZA883957B publication Critical patent/ZA883957B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA883957A 1987-06-03 1988-06-03 Compositions of catecholic butanes for use in treating tumors ZA883957B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/057,481 US5008294A (en) 1985-02-11 1987-06-03 Methods of treating tumors with compositions of catecholic butanes

Publications (1)

Publication Number Publication Date
ZA883957B true ZA883957B (en) 1989-02-22

Family

ID=22010825

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883957A ZA883957B (en) 1987-06-03 1988-06-03 Compositions of catecholic butanes for use in treating tumors

Country Status (9)

Country Link
US (1) US5008294A (xx)
EP (1) EP0297733A3 (xx)
JP (1) JPS6479112A (xx)
KR (1) KR970009883B1 (xx)
AU (2) AU1736088A (xx)
CA (1) CA1334170C (xx)
ES (1) ES2020011A6 (xx)
IL (1) IL86554A0 (xx)
ZA (1) ZA883957B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
DE4307976A1 (de) * 1993-03-15 1994-09-22 Beiersdorf Ag Neue Verwendung von Aknemitteln
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
AU698313B2 (en) * 1994-03-14 1998-10-29 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
US6365787B1 (en) 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
US5627187A (en) * 1995-04-12 1997-05-06 Katz; Bruce E. 5-FU for treating actinic kerotoses
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
KR19990069211A (ko) * 1998-02-05 1999-09-06 성재갑 타이로시나제 저해활성을 갖는 신규 폴리하이드록시-디페닐알칸유도체 및 그의 제조방법
FR2785804B1 (fr) * 1998-11-17 2002-10-18 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait de larrea divaricata ou de larrea tridentata pour ralentir le vieillissement cutane
US6608108B2 (en) 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
US6214874B1 (en) * 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
FR2830195B1 (fr) * 2001-10-03 2004-10-22 Sederma Sa Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
US20040156799A1 (en) * 2002-06-04 2004-08-12 Zigang Dong Cancer treatment method and compositions
FI20021184A (fi) 2002-06-19 2003-12-20 Hormos Nutraceutical Oy Ltd Lignaanivalmisteita
US7728036B2 (en) * 2003-05-20 2010-06-01 Erimos Pharmaceuticals, Llc Methods for delivery of catecholic butanes for treatment of tumors
US20060141029A1 (en) * 2003-05-20 2006-06-29 Erimos Pharmaceuticals Llc Methods and compositions for delivery of catecholic butanes for treatment of diseases
WO2004112696A2 (en) * 2003-05-20 2004-12-29 Erimos Pharmaceutical Llp Methods and compositions for delivery of catecholic butanes for treatment of diseases
KR100567431B1 (ko) * 2004-01-08 2006-04-04 황재관 리그난계 화합물을 유효성분으로 함유하는 여드름 치료 또는 예방용 조성물
ES2336009T3 (es) * 2004-01-30 2010-04-07 Medivir Ab Inhibidores de la ns-3 serina proteasa del vhc.
US7420105B2 (en) 2004-03-11 2008-09-02 Carlsberg A/S Barley for production of flavor-stable beverage
CN100440843C (zh) * 2004-05-12 2008-12-03 华为技术有限公司 一种环网及其业务实现方法
WO2005117849A1 (en) 2004-05-28 2005-12-15 Unigen Pharmaceuticals, Inc. Diarylalkanes as potent inhibitors of binuclear enzymes
WO2006014669A2 (en) * 2004-07-20 2006-02-09 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
US8440648B2 (en) * 2004-07-20 2013-05-14 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
CA2595617C (en) * 2005-01-27 2014-06-03 Erimos Pharmaceuticals Llc Formulations for injection of catecholic butanes, including ndga compounds, into animals
WO2007101111A2 (en) * 2006-02-23 2007-09-07 Erimos Pharmaceuticals Llc Methods of treating influenza viral infections
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
ES2476249T3 (es) * 2006-10-02 2014-07-14 Erimos Pharmaceuticals Llc Derivados del NDGA tetrasustituidos por medio de enlaces éter y enlaces carbamatos y sus síntesis y usos farmacéuticos
WO2008095195A2 (en) * 2007-02-02 2008-08-07 Nereus Pharmaceuticals, Inc. Lyophilized formulations of salinosporamide a
US7946439B1 (en) 2007-04-09 2011-05-24 Tech Serv LLC Protective steel membrane system and method of erection for secondary containment for an above ground storage tank
CN102099001A (zh) 2008-07-21 2011-06-15 尤尼根公司 皮肤增白(增亮)化合物系列
WO2010011117A2 (ko) * 2008-07-25 2010-01-28 국립암센터 Ｎｄｇａ를 포함하는 트란스글루타미나제 억제용 조성물
US8710104B2 (en) * 2008-11-07 2014-04-29 Triact Therapeutics, Inc. Catecholic butanes and use thereof for cancer therapy
EP3822246A1 (en) 2011-03-24 2021-05-19 Unigen, Inc. Compounds and methods for preparation of diarylpropanes
EP2961412A4 (en) 2013-02-26 2016-11-09 Triact Therapeutics Inc CANCER THERAPY
US9381246B2 (en) 2013-09-09 2016-07-05 Triact Therapeutics, Inc. Cancer therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934034A (en) * 1972-08-21 1976-01-20 Sandoz, Inc. Hydroxy substituted diphenylalkyls for treatment of lipidemia
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4695590A (en) * 1986-05-05 1987-09-22 California Health Technologies Method for retarding aging

Also Published As

Publication number Publication date
CA1334170C (en) 1995-01-31
ES2020011A6 (es) 1991-07-16
EP0297733A2 (en) 1989-01-04
US5008294A (en) 1991-04-16
AU1736088A (en) 1988-12-08
IL86554A0 (en) 1988-11-15
EP0297733A3 (en) 1990-12-05
JPS6479112A (en) 1989-03-24
KR890000092A (ko) 1989-03-11
AU2099092A (en) 1992-10-08
KR970009883B1 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
ZA883957B (en) Compositions of catecholic butanes for use in treating tumors
DE3377263D1 (en) Skin treatment composition
GB8320603D0 (en) Compositions for treating hair
GB2157280B (en) Well treating composition
JPS5634621A (en) Dimethylsulfoxideecontaining treating composition
EP0286261A3 (en) Hair treatment composition
GB8700398D0 (en) Compositions for surface treatment
GB8333431D0 (en) Hair treatment composition
ZA842371B (en) Tanning composition
IL88745A0 (en) Mixed compositions for treating hypercholesterolemia
GB8813576D0 (en) Composition & use
ZA903136B (en) Hair treatment composition
ZA859008B (en) The treatment of tumors in mammals
GB2140297B (en) Hair treatment compositions
HUT47424A (en) Skin-regenerating cosmetical composition
GB2132653B (en) Hair treatment compositions
HK51694A (en) Composition for treating pigmentation
ZA834402B (en) Skin treatment compositions
ZA83662B (en) Skin treatment composition
GB8410462D0 (en) Skin preparation composition
EP0088621A3 (en) Compositions for use in accelerating onset of sleep
GB2146528B (en) Composition for treating the skin or hair compositions
IL64637A0 (en) Composition for treating external tissues
IL64638A0 (en) Composition for treating external tissues
GB8712576D0 (en) Compositions for surface treatment